The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J04 | Antimycobacterials | |
| 3 | J04A | Drugs for treatment of tuberculosis | |
| 4 | J04AM | Combinations of drugs for treatment of tuberculosis |
| Code | Title | |
|---|---|---|
| J04AM01 | Streptomycin and isoniazid | |
| J04AM02 | Rifampicin and isoniazid | |
| J04AM03 | Ethambutol and isoniazid | |
| J04AM04 | Thioacetazone and isoniazid | |
| J04AM05 | Rifampicin, pyrazinamide and isoniazid | |
| J04AM06 | Rifampicin, pyrazinamide, ethambutol and isoniazid |
| Active Ingredient | Description | |
|---|---|---|
| Rifampicin and Isoniazid |
Rifampicin and isoniazid are active bactericidial antituberculosis drugs which are particularly active against the rapidly growing extracellular organisms and also have bactericidal activity intracellularly. Rifampicin has activity against slow- and intermittently-growing M. tuberculosis. Isoniazid acts against actively growing tubercle bacilli. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| RIFINAH Coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
